Source: Annual Congress 2010 - New mechanisms in chronic lung diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Said, S. Hamidi (Northport, United States Of America). The VIP gene is a dominant modulator of the pulmonary circulation. Eur Respir J 2010; 36: Suppl. 54, 5545

Member's Comments

No comment yet.

Related content which might interest you: Is TGFb a central mediator in the development of pulmonary fibrosis? Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH) Source: Annual Congress 2006 - Cellular mechanisms of airway disease Year: 2006 Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Macitentan modulates pulmonary mRNA levels of gremlin 1 in a rat model of pulmonary arterial hypertension Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Classical transient receptor potential channel 6 (TRPC6) is a key regulator of acute hypoxic pulmonary vasoconstriction Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension Source: Annual Congress 2007 - Pulmonary hypertension Year: 2007 Expression vasoactive intestinal peptide and related receptors in overcirculation-induced pulmonary hypertension in piglets Source: Eur Respir J 2006; 28: Suppl. 50, 659s Year: 2006 Pulmonary arterial hypertension (PAH) in mice lacking the vasoactive intestinal polypeptide (VIP) gene: morphometric evidence for vascular remodeling Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals Year: 2006 Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models Year: 2011 Optimization of tissue targeting properties of macitentan, a new dual endothelin receptor antagonist, improves its efficacy in a rat model of pulmonary fibrosis associated with pulmonary arterial hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 The pathophysiological role of novel pulmonary arterial hypertension gene SOX17 Source: Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020 Year: 2021 Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion Source: Eur Respir J 2008; 31: 135-139 Year: 2008 Expression and role of the nerve growth factor NGF in pulmonary hypertension Source: Annual Congress 2011 - Pathobiology of experimental pulmonary hypertension Year: 2011 Expression of the serotonin 1b receptor in experimental pulmonary hypertension Source: Eur Respir J 2003; 22: 408-412 Year: 2003 Endothelin receptor expression in idiopathic pulmonary arterial hypertension: effect of bosentan and epoprostenol treatment Source: Eur Respir J 2011; 38: 851-860 Year: 2011 Effect of medroxyprogesterone on arterial blood gases, leptin and neuropeptide Y in postmenopausal females Source: Eur Respir J 2002; 20: 1413-1418 Year: 2002 NGF induces pulmonary arterial hyperreactivity through connexin 43 increased expression Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Late Breaking Abstract - NGF induces pulmonary arterial hyperreactivity through increased connexin-43 expression: potential role in pulmonary hypertension Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Dependence of mean pulmonary artery pressure from cytokine inflammation activity and remodeling index of pulmonary circulation Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006